Saturday, July 11, 2026

pharma · Vestibular Disorder

Eye & ENT

Eye & ENT is a pharma organization headquartered in CN. Primary therapeutic focus areas include Vestibular Disorder. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity fr

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Clinical program

Usual care

Unknown · small molecule · Vestibular Disorder

Usual care for Vestibular Disorder is a Unknown program (small_molecule) at Eye & ENT Hospital of Fudan University with 1 ClinicalTrials.gov record(s).

Internal code 202311-MD-ITG-VRT

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Eye & ENT Hospital of Fudan University
Phase
Unknown
Modality
small_molecule
Indication
Vestibular Disorder
Status
active
Trials
1

Clinical trials